Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10868800rdf:typepubmed:Citationlld:pubmed
pubmed-article:10868800lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:10868800lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:10868800lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:10868800lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:10868800lifeskim:mentionsumls-concept:C0019164lld:lifeskim
pubmed-article:10868800lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:10868800pubmed:issue2lld:pubmed
pubmed-article:10868800pubmed:dateCreated2000-9-21lld:pubmed
pubmed-article:10868800pubmed:abstractTextWe have efficiently generated mouse monoclonal antibodies (MAbs), which bind specifically to amino acids 21-47 of the preS1 domain of hepatitis B virus (HBV) by immunizing mice with the preS1 peptide (amino acids, aa 1-56) conjugated to keyhole limpet hemocyanin. Hybridomas were screened by an indirect enzyme-linked immunosorbent assay (ELISA) using the purified preS1 peptide as a coated antigen. Eighteen positive hybridomas were selected and subjected to isotyping. Of these, 5 clones secreted immunoglobulin G (IgG) and 13 clones secreted IgM. Four (KR1, KR2, KR3, and KR4) of the 5 IgG MAbs bound to preS1 peptide (aa 21-47). Epitope mapping using bacterially expressed GST fusion proteins revealed that three clones (KR2, KR3, KR4) (IgG1, K) recognize aa 21-35, while KR1 (IgG2a, K) recognizes aa 35-47 of the preS1. These MAbs immunoprecipitated HBV particles, demonstrating that they bind to native HBV particles.lld:pubmed
pubmed-article:10868800pubmed:languageenglld:pubmed
pubmed-article:10868800pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:citationSubsetIMlld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10868800pubmed:statusMEDLINElld:pubmed
pubmed-article:10868800pubmed:monthAprlld:pubmed
pubmed-article:10868800pubmed:issn0272-457Xlld:pubmed
pubmed-article:10868800pubmed:authorpubmed-author:KangY JYJlld:pubmed
pubmed-article:10868800pubmed:authorpubmed-author:KimH SHSlld:pubmed
pubmed-article:10868800pubmed:authorpubmed-author:KimY KYKlld:pubmed
pubmed-article:10868800pubmed:authorpubmed-author:HuqIIlld:pubmed
pubmed-article:10868800pubmed:authorpubmed-author:HongH JHJlld:pubmed
pubmed-article:10868800pubmed:authorpubmed-author:RyuC JCJlld:pubmed
pubmed-article:10868800pubmed:authorpubmed-author:OkJ HJHlld:pubmed
pubmed-article:10868800pubmed:issnTypePrintlld:pubmed
pubmed-article:10868800pubmed:volume19lld:pubmed
pubmed-article:10868800pubmed:ownerNLMlld:pubmed
pubmed-article:10868800pubmed:authorsCompleteYlld:pubmed
pubmed-article:10868800pubmed:pagination185-9lld:pubmed
pubmed-article:10868800pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:meshHeadingpubmed-meshheading:10868800...lld:pubmed
pubmed-article:10868800pubmed:year2000lld:pubmed
pubmed-article:10868800pubmed:articleTitleMouse monoclonal antibodies to hepatitis B virus preS1 produced after immunization with recombinant preS1 peptide.lld:pubmed
pubmed-article:10868800pubmed:affiliationAntibody Engineering Research Unit, Korea Research Institute of Bioscience and Biotechnology, Yuseong, Taejon.lld:pubmed
pubmed-article:10868800pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10868800pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10868800lld:pubmed